The largest database of trusted experimental protocols

N glycolylneuraminic acid neu5gc

Manufactured by Merck Group
Sourced in United States, Germany

N-glycolylneuraminic acid (Neu5Gc) is a type of sialic acid, which are a family of nine-carbon monosaccharides found on the surface of many cells. Neu5Gc is a structural variant of the more common sialic acid, N-acetylneuraminic acid (Neu5Ac). Neu5Gc is naturally present in most mammals, but not in humans due to a genetic mutation.

Automatically generated - may contain errors

3 protocols using n glycolylneuraminic acid neu5gc

1

Analysis of Sialic Acids and Oligosaccharides in Dairy Powders

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial cow and goat lactose powders within 6 mon after manufacture were purchased from a local store in Seoul, Korea. The reference standards (N-acetylneuraminic acid [Neu-5Ac] and N-glycolylneuraminic acid [Neu-5Gc]) for sialic acid analysis were obtained from Sigma-Aldrich (USA). 3-Sialyllactose, 6-sialyllactose (USA), and Sunoligo L500 (Samyang Genex, Korea) containing >50% (w/v) of GOS were used as reference standards for oligosaccharide analysis. Proteinase K and activated charcoal powder (Samchun Chemicals, Korea) were used for sample pretreatment. Other chemicals and reagents were obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
2

E. coli Growth with Sialic Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
E. coli strains were grown at 37 °C aerobically in lysogeny broth (LB) (10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, pH 7.5) or in minimal medium (MM). MM is M9 mineral medium (33.7 mM Na2HPO4, 22.0 mM KH2PO4, 8.55 mM NaCl, 9.35 mM NH4Cl) supplemented with 2 mM MgSO4 and 0.1 mM CaCl2. As carbon and energy source, either 27.8 mM [0.5% w/v] glucose, 6.47 mM [0.2% w/v] 5-N-acetylneuraminic acid (Neu5Ac) or 6.15 mM [0.1% w/v] N-glycolylneuraminic acid (Neu5Gc) (all purchased from Sigma-Aldrich, Taufkirchen, Germany) was added. If appropriate, the following antibiotics were used: ampicillin sodium salt (150 μg/ml) or kanamycin (50 μg/ml). For solid media, 1.5% agar (w/v) was added. For all growth experiments, bacterial strains were grown in LB medium overnight at 37 °C aerobically, washed twice in PBS and then adjusted to an optical density at 600 nm (OD600) of 0.005 in the desired liquid growth medium, or streaked on agar plates. Growth curves were obtained from bacterial cultures incubated at 37 °C with gentle agitation in 96-well microtitre plates containing 200 μl medium. The OD600 was measured by an automatic reader (Epoch2T; BioTek, Bad Friedrichshall, Germany) at appropriate time intervals as indicated.
+ Open protocol
+ Expand
3

Vibrio cholerae Growth Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All bacterial strains and plasmids used in this study are listed in Table S1 in the supplemental material. All V. cholerae strains were grown aerobically with aeration (225 rpm) at 37°C in Luria Bertani (LB) broth (Fisher Scientific, Waltham, MA) with a 1% NaCl concentration. For growth analysis on intestinal mucus, mucus sugars, and sialic acid derivatives as sole carbon sources, M9 minimal medium was supplemented with 0.02 mM MgSO4 and 0.1 mM CaCl2. M9 minimal medium supplemented with intestinal mucus (M9M) (30 µg/ml) or glucose (M9G) was used or N-acetylglucosamine, d-ribose, d-mannose, d-gluconate, or d-galactose (all 10 mM), or Neu5Ac (3 mM), 2-keto-3-deoxy-d-glycero-d-galacto-nononic acid (KDN) (4 mM), or N-glycolylneuraminic acid (Neu5Gc) (3 mM) (Sigma-Aldrich) was added to M9 to serve as the carbon source. Antibiotics were used at the following concentrations: streptomycin (Sm) at 200 µg/ml, ampicillin (Amp) at 100 µg/ml, chloramphenicol (Cm) at 25 µg/ml, and kanamycin at 50 µg/ml.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!